Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -71.63%233.7M | 341.77%980.65M | 477.25%823.75M | 5.85%221.98M | 49.01%142.7M | 651.38%209.71M | 638.63%95.76M | 124.18%27.91M | 396.17%12.97M | -14.21%12.45M |
| Operating income | -71.63%233.7M | 341.77%980.65M | 477.25%823.75M | 5.85%221.98M | 49.01%142.7M | 651.38%209.71M | 638.63%95.76M | 124.18%27.91M | 396.17%12.97M | -14.21%12.45M |
| Cost of sales | -43.77%-21.65M | 4.77%-29.09M | 17.05%-15.06M | -38.84%-30.54M | -261.56%-18.15M | -561.00%-22M | -93.94%-5.02M | -69.28%-3.33M | ---2.59M | 6.20%-1.97M |
| Operating expenses | -43.77%-21.65M | 4.77%-29.09M | 17.05%-15.06M | -38.84%-30.54M | -261.56%-18.15M | -561.00%-22M | -93.94%-5.02M | -69.28%-3.33M | -2.59M | 6.20%-1.97M |
| Gross profit | -73.78%212.05M | 397.05%951.57M | 549.30%808.69M | 1.99%191.44M | 37.25%124.55M | 663.62%187.71M | 774.54%90.74M | 134.47%24.58M | 297.09%10.38M | -15.57%10.48M |
| Selling expenses | -53.72%-137.79M | -0.31%-196M | -7.58%-89.64M | -24.12%-195.39M | -16.80%-83.32M | -229.69%-157.42M | -573.43%-71.34M | -3,380.17%-47.75M | ---10.59M | ---1.37M |
| Administrative expenses | -14.60%-99.69M | -3.34%-187.13M | 4.76%-86.99M | -6.14%-181.08M | -10.92%-91.34M | -18.87%-170.6M | -28.82%-82.35M | -11.28%-143.51M | -3.61%-63.93M | 20.21%-128.97M |
| Research and development expenses | -19.02%-528.56M | -33.99%-947.25M | -43.34%-444.08M | 4.86%-706.97M | 9.25%-309.81M | 3.05%-743.1M | -7.52%-341.41M | -35.77%-766.49M | -26.28%-317.54M | -21.71%-564.57M |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---19.07M | ---16.73M | ---- | ---- |
| Special items of operating profit | -134.48%-3.53M | -10.77%48.28M | -20.29%10.24M | 9.77%54.11M | -39.33%12.85M | -58.10%49.3M | 34.96%21.17M | 672.20%117.65M | 306.18%15.69M | 101.76%15.24M |
| Operating profit | -381.26%-557.52M | 60.55%-330.52M | 157.11%198.22M | -0.45%-837.88M | 13.72%-347.08M | -0.22%-834.11M | -9.91%-402.25M | -24.37%-832.25M | -15.04%-366M | 54.72%-669.19M |
| Financing cost | 18.42%-27.8M | 32.90%-64.46M | 35.36%-34.08M | -81.98%-96.06M | ---52.72M | ---52.79M | ---- | ---- | -358.26%-8.38M | -46.35%-6.26M |
| Share of profit from joint venture company | 100.08%1K | -126.12%-281K | -738.78%-1.25M | 487.05%1.08M | --196K | ---278K | ---- | ---- | ---- | ---- |
| Earning before tax | -459.32%-585.31M | 57.63%-395.26M | 140.76%162.9M | -5.15%-932.86M | 0.66%-399.6M | -6.60%-887.17M | -7.45%-402.25M | -23.21%-832.25M | -17.00%-374.38M | 54.43%-675.45M |
| Tax | -7,888.41%-5.51M | -245.80%-10.43M | 97.49%-69K | 68.31%7.15M | 38.73%-2.75M | -91.47%4.25M | -94.36%-4.48M | 2,408.85%49.83M | -387.89%-2.31M | -234.71%-2.16M |
| After-tax profit from continuing operations | -462.86%-590.82M | 56.18%-405.68M | 140.47%162.83M | -4.85%-925.71M | 1.08%-402.35M | -12.84%-882.92M | -7.98%-406.73M | -15.47%-782.42M | -18.02%-376.68M | 54.24%-677.61M |
| Earning after tax | -462.86%-590.82M | 56.18%-405.68M | 140.47%162.83M | -4.85%-925.71M | 1.08%-402.35M | -12.84%-882.92M | -7.98%-406.73M | -15.47%-782.42M | -18.02%-376.68M | 54.24%-677.61M |
| Minority profit | 68.00%-56K | -229.33%-247K | -8,850.00%-175K | ---75K | --2K | ---- | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | -462.43%-590.77M | 56.20%-405.43M | 140.51%163M | -4.84%-925.64M | 1.08%-402.35M | -12.84%-882.92M | -7.98%-406.73M | -15.47%-782.42M | -18.02%-376.68M | 54.24%-677.61M |
| Basic earnings per share | -408.93%-1.73 | 59.15%-1.34 | 138.10%0.56 | 2.09%-3.28 | 4.55%-1.47 | -9.12%-3.35 | -1.32%-1.54 | 2.23%-3.07 | 0.65%-1.52 | 75.26%-3.14 |
| Diluted earnings per share | -414.55%-1.73 | 59.15%-1.34 | 137.41%0.55 | 2.09%-3.28 | 4.55%-1.47 | -9.12%-3.35 | -1.32%-1.54 | 2.23%-3.07 | 0.65%-1.52 | 75.26%-3.14 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.